241Am removal by DTPA vs. occurrence of skeletal malignancy.
241Am removal by DTPA vs. occurrence of skeletal malignancy.
复制标题
DTPA 去除 241Am 与骨骼恶性肿瘤的发生。
DOI：
10.1097/00004032-199812000-00008
复制
发表时间：
1998
期刊：
影响因子：
2.2
通讯作者：
Mays,CW
中科院分区：
文献类型：
--
作者：
Lloyd,RD;Taylor,GN;Mays,CW
Beagle dogs injected with 241 Am and treated subsequently with DTPA exhibited a reduced occurrence of skeletal malignancies and increased lifespans when compared to corresponding untreated animals also given 241 Am. Whereas 92% of dogs given about 11 kBq 241 Am kg− 1 and not treated with DTPA developed bone cancer (skeletal dose about 5.9 Gy), skeletal malignancy was seen in only 40% and 27%, respectively, among two groups of DTPA-treated animals injected with 11 kBq kg− 1 (doses of 5.7 and 1.7 Gy). The median lifespan among the untreated dogs was 1,728 d, but the median lifespans in the DTPA-treated groups were 2,478 and 3,654 d, respectively. Untreated dogs with a skeletal dose averaging about 2 Gy had 53% bone cancer occurrence and a median lifespan of 3,227 d. These data did not enable us to address the question of whether the reduction in cancer occurrence was proportional to, greater than, or less than the reduction in skeletal dose, but the third possibility seems unlikely.
登录
查看更多内容
注入颗粒钚后 DTPA 处理的有效性。
影响因子：
2.6
作者：
Bruenger,FW;Taylor,DM;Taylor,GN;Lloyd,RD
通讯作者：
Lloyd,RD
通过 DTPA 对比格犬中的 241Am 进行修饰。
影响因子：
3.4
作者：
R. D. Lloyd;S. S. Mc Farland;G. Taylor;J. Williams;C. W. Mays
通讯作者：
C. W. Mays
通过螯合疗法降低 239Pu 的癌症风险。
影响因子：
3.4
作者：
Jones,CW;Mays,CW;Taylor,GN;Lloyd,RD;Packer,SM
通讯作者：
Packer,SM
口服部分亲脂性聚氨基羧酸对钚和镅脱色的持续时间和剂量相关影响。
DOI：
--
发表时间：
1993
期刊：
The Journal of pharmacology and experimental therapeutics
影响因子：
--
作者：
Miller,SC;Bruenger,FW;Kuswik-Rabiega,G;Liu,G;Lloyd,RD
通讯作者：
Lloyd,RD
生物测定原理
DOI：
--
发表时间：
1968
期刊：
影响因子：
--
作者：
C. M. Woolf
通讯作者：
C. M. Woolf